CoChat

Hepatoprotective and anti‐fibrotic functions of interleukin‐22: Therapeutic potential for the treatment of alcoholic liver disease

Open access
Kong, Xiaoni, Feng, Dechun, Mathews, Stephanie, Gao, Bin · 2013 · Journal of Gastroenterology and Hepatology
Cited by 108

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Abstract

graphic Interleukin‐22 (IL‐22) plays a key role in promoting antimicrobial immunity and tissue repair at barrier surfaces by binding to the receptors IL‐22 R 1, which is generally thought to be expressed exclusively in epithelial cells, and IL‐10 R 2. Our laboratory previously demonstrated that IL‐22 plays an important role in ameliorating liver injury in many rodent models by targeting hepatocytes that express high levels of IL‐22 R 1 and IL‐10 R 2. Recently, we have identified high expression levels of IL‐22 R 1 and IL‐10 R 2 in liver progenitor cells and hepatic stellate cells (HSCs). Overexpression of IL‐22 in vivo or treatment with IL‐22 in vitro promotes proliferation of liver progenitor cells via a signal transducer and activator of transcription 3 (STAT 3)‐dependent mechanism. IL‐22 treatment also prevents HSC apoptosis in vitro and in vivo. Surprisingly, overexpression of IL‐22, via either gene targeting or exogenous administration of adenovirus expressing IL‐22, reduces liver fibrosis and accelerates the resolution of liver fibrosis during recovery. The anti‐fibrotic effects of IL‐22 are mediated via the activation of STAT 3 in HSCs and subsequent induction of suppressor of cytokine signaling 3, which induces HSC senescence. Taken together, the hepatoprotective, mitogenic, and anti‐fibrotic effects of IL‐22 are beneficial in ameliorating alcoholic liver injury. Importantly, due to the restricted expression of IL‐22 R 1, IL‐22 therapy is expected to have few side effects, thus making IL‐22 a potential candidate for treatment of alcoholic liver disease.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/jgh.12032

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Cited by

See all 108

Metadata

Authors
Kong, X., Feng, D., Mathews, S., & Gao, B.
Venue
Journal of Gastroenterology and Hepatology
Publisher
Wiley
Published
2013-07-15
Volume
28
Issue
S1
Pages
56-60
ISSN
  • 0815-9319 (ISSN-L)
  • 1440-1746
OpenAlex
W1864605302
Cited by
108
References
9
FWCI
4.77
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Hepatoprotective and anti‐fibrotic functions of interleukin‐22: Therapeutic potential for the treatment of alcoholic liver disease. https://app.cochat.ai/papers/10.1111/jgh.12032
The paper
Kong, X., Feng, D., Mathews, S., & Gao, B. (2013). Hepatoprotective and anti‐fibrotic functions of interleukin‐22: Therapeutic potential for the treatment of alcoholic liver disease. Journal of Gastroenterology and Hepatology. https://doi.org/10.1111/jgh.12032

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.